Scientists are expressing some doubts about the Food and Drug Administration’s emergency use authorization for convalescent plasma as a treatment for Covid-19 patients. In a Sunday news briefing, President Donald Trump touted the treatment as a “breakthrough.” Former FDA chief Dr. Scott Gottlieb told CNBC that while there was enough data to justify the authorization, the treatment is not a “home run.”
The following data was compiled by Johns Hopkins University:
- Global cases: More than 23.4 million
- Global deaths: At least 809,300
- U.S. cases: More than 5.7 million
- U.S. deaths: At least 176,800
This article was originally published by Cnbc.com. Read the original article here.